Long

Corona Stock : Ready for 60% !

Updated

genOway is a biotechnology company specializing in the design and development of molecular, cellular and animal research models with high added value for the biopharmaceutical, chemical, agrochemical and agrifood industries as well as for academic research. genOway is a leading company in its market. It bases its development on the combination of a broad and exclusive technological platform and strong intellectual property combining patents and operating licenses. genOway has concluded numerous commercial contracts with the leaders of the pharmaceutical industry (BMS, Janssen, Novartis, Pfizer, etc.), and with the most prestigious academic research centers (King's College and University of Manchester in England, Harvard, Caltech and the National Institute of Health in the United States, the Pasteur Institute in France, the NGFN and the Max Planck Institute in Germany, etc.).

Trade active

Target : €7
SL : €3.43

Note

Current Market Cap: €24M
2019 Turn-over : €9.4M
2022 Turn-over target : €30M

The potential is enormous!

Note

SL reached! I bought 3.31 €.

sharl92

Also on:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.